| Literature DB >> 32299355 |
Xiaofen Wu1,2, Ting Chen1,3, Da Huo1,3,4, Zonghe Yu1,3,4, Yao Ruan1,2, Chuhang Cheng1,2, Xiao Jiang1,3,4, Chunhua Ren5,6,7.
Abstract
BACKGROUND: The sea cucumber Holothuria leucospilota belongs to echinoderm, which is evolutionally the most primitive group of deuterostomes. Sea cucumber has a cavity between its digestive tract and the body wall that is filled with fluid and suspended coelomic cells similar to blood cells. The humoral immune response of the sea cucumber is based on the secretion of various immune factors from coelomocytes into the coelomic cavity. The aim of this study is to lay out a foundation for the immune mechanisms in echinoderms and their origins in chordates by using RNA-seq.Entities:
Keywords: Coelomocytes; Cytokines; Differentailly expressed genes; Immune response; RNA-seq; Sea cucumber; Transcriptome
Mesh:
Substances:
Year: 2020 PMID: 32299355 PMCID: PMC7161275 DOI: 10.1186/s12864-020-6698-6
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Experimental design and transcriptome information. a Experimental design. Sea cucumber coelomocytes isolated from H. leucospilota were challenged with LPS (10 μg/ml), Poly (I:C) (10 μg/ml) and V.harveyi (107 cell/ml) for 24 h with three biological duplicates. b The length distribution of all-Unigene. The X-axis represents the sequence size, and the Y-axis represents the number of Mix-Unigene. The orange bar shows the number of unigene which is the representative sequences, and the blue bar shows the number of transcripts which include the rough sequences. c Venn diagram of Unigene annotation. The databases used for gene annotation include NR、KOG、KEGG、SwissProt and InterPro. d Species distribution of Unigene annotation in NR database
Functional annotation analysis
| Total | NR | NT | SwissPprot | KEGG | KOG | InterPro | GO | Intersection | Overall | |
|---|---|---|---|---|---|---|---|---|---|---|
| No. of gene | 73,472 | 19,156 | 3990 | 14,803 | 15,277 | 13,615 | 15,624 | 7097 | 1285 | 20,926 |
| Percentage | 100% | 26.07% | 5.43% | 20.15% | 20.79% | 18.53% | 21.27% | 9.66% | 1.75% | 28.48% |
Fig. 2Comparative transcriptome analysis of DEGs among different immune challenges. a Venn diagram of unique and common DEGs among the immune challenges of LPS、Poly (I:C) and V. harveyi. b the number of up- and down-regulated DEGs in each immune challenge group compared with control group (the first 3 combination bar) and the pairwise comparison of the three different immune challenge groups (the last 3 combination bar). c Volcano map of DEGs in LPS-vs-CT group: X-axis represents the fold change value after log2 conversion, and Y-axis represents the fold change after -log10 conversion. Red dots represent the up-regulated DEGs, blue dots represent the down-regulated DEGs, and gray dots represents the non-DEGs. d comparison results between RNA-Seq by RT-qPCR data in LPS-vs-CT group. X axis shows the fold changes of gene expression in RT-qPCR data, while Y axis represents the fold changes of gene expression in RNA-Seq data
Fig. 3Co-expressed DEGs of functional classification. a GO classification of a co-expressed gene. The X-axis represents the enrichment factor value, and the Y-axis represents the path name. b Functional classification of KEGG of co-expressed genes. c Pathway enrichment distribution of co-expressed genes. The X-axis represents the enrichment factor value, and the Y-axis represents the path name. The color represents q-value, which is corrected p-value ranging from 0~1, and less q-value means greater intensiveness. The size of the point represents the number of DEGs (the larger the point, the larger the number; the smaller the point, the smaller the number). Rich Factor refers to the enrichment Factor value, which is the quotient between the foreground value (number of DEGs) of a certain pathway on the annotation and the background value (number of all genes) of a certain pathway on the annotation. The larger the data is, the more obvious the enrichment result will be. d GO classification and enrichment of differentially expressed genes under different immune challenges. The Y axis (horizontal direction) represents the number of genes, and the X axis (vertical direction) represents the specific classification under the three functional categories of GO. The red bars represent the GO classification entries annotated by the DEGs in LPS compared to the control group, and accordingly, the purple and blue represent those of Poly (I:C) and V. harveyi
The top 10 KEGG pathways with the highest enrichment of co-expressed DEGs
| Pathway ID | DEGs annotation in the pathway | All genes annotation in the pathway | Pathway annotation | |
|---|---|---|---|---|
| 15 (3.85%) | 50 (0.33%) | 9.73403e-13 | ||
| 16 (4.1%) | 84 (0.55%) | 3.141596e-10 | Complement and coagulation cascades | |
| 24 (6.15%) | 271 (1.77%) | 1.258897e-07 | Tuberculosis | |
| 10 (2.56%) | 53 (0.35%) | 7.672128e-07 | Systemic lupus erythematosus | |
| 22 (5.64%) | 291 (1.9%) | 5.889262e-06 | Phagosome | |
| 18 (4.62%) | 213 (1.39%) | 9.237491e-06 | Dorso-ventral axis formation | |
| 13 (3.33%) | 119 (0.78%) | 1.082585e-05 | Pertussis | |
| 11 (2.82%) | 89 (0.58%) | 1.597061e-05 | Leishmaniasis | |
| 15 (3.85%) | 172 (1.13%) | 3.550144e-05 | Prion diseases |
The top 10 immune-related KEGG pathways with the highest number of co-expressed DEGs
| Pathway ID | DEGs annotation in the pathway | All genes annotation in the pathway | Pathway annotation | |
|---|---|---|---|---|
| 16 (4.1%) | 84 (0.55%) | 3.141596e-10 | Complement and coagulation cascades | |
| 15 (3.85%) | 218 (1.43%) | 0.0004926241 | Th1 and Th2 cell differentiation | |
| 7 (1.79%) | 115 (0.75%) | 0.02799556 | Natural killer cell mediated cytotoxicity | |
| 10 (2.56%) | 213 (1.39%) | 0.04710404 | Platelet activation | |
| 9 (2.31%) | 208 (1.36%) | 0.08609158 | Leukocyte transendothelial migration | |
| 7 (1.79%) | 155 (1.01%) | 0.102463 | Fc gamma R-mediated phagocytosis | |
| 5 (1.28%) | 118 (0.77%) | 0.1839742 | Toll-like receptor signaling pathway | |
| 4 (1.03%) | 88 (0.58%) | 0.1874437 | Th17 cell differentiation | |
| 7 (1.79%) | 188 (1.23%) | 0.2058452 | Chemokine signaling pathway | |
| 5 (1.28%) | 127 (0.83%) | 0.2245483 | IL-17 signaling pathway |
The top 10 KEGG pathways with the highest enrichment of DEGs in groups with different immune challenges
| Pathway ID | DEGs annotation in the pathway | All genes annotation in the pathway | Pathway annotation | |
|---|---|---|---|---|
| | 40 (3.26%) | 163 (1.07%) | 1.040587e-10 | ABC transporters |
| | 41 (3.34%) | 274 (1.79%) | 7.710349e-05 | Ubiquitin mediated proteolysis |
| | 15 (1.22%) | 88 (0.58%) | 0.004140363 | Alanine, aspartate and glutamate metabolism |
| | 21 (1.71%) | 147 (0.96%) | 0.006927921 | Prostate cancer |
| | 7 (0.57%) | 30 (0.2%) | 0.008355145 | Mucin type O-glycan biosynthesis |
| | 43 (3.5%) | 374 (2.45%) | 0.01077703 | Thyroid hormone signaling pathway |
| | 30 (2.44%) | 247 (1.62%) | 0.01495566 | Gastric cancer |
| | 28 (2.28%) | 227 (1.49%) | 0.01511225 | Notch signaling pathway |
| | 12 (0.98%) | 76 (0.5%) | 0.01751861 | Fat digestion and absorption |
| | 15 (1.22%) | 105 (0.69%) | 0.0203857 | Inositol phosphate metabolism |
| | 22 (1.45%) | 105 (0.69%) | 0.0005556445 | Inositol phosphate metabolism |
| | 30 (1.98%) | 167 (1.09%) | 0.0009830988 | Apoptosis – fly |
| | 26 (1.71%) | 138 (0.9%) | 0.001015626 | Glucagon signaling pathway |
| | 23 (1.52%) | 124 (0.81%) | 0.002380328 | Jak-STAT signaling pathway |
| | 19 (1.25%) | 100 (0.65%) | 0.004151803 | Non-small cell lung cancer |
| | 24 (1.58%) | 142 (0.93%) | 0.006645948 | Phosphatidylinositol signaling system |
| | 25 (1.65%) | 151 (0.99%) | 0.007416318 | Glycerophospholipid metabolism |
| | 15 (0.99%) | 78 (0.51%) | 0.009115605 | Amino sugar and nucleotide sugar metabolism |
| | 21 (1.38%) | 124 (0.81%) | 0.01041359 | Renal cell carcinoma |
| | 39 (2.57%) | 274 (1.79%) | 0.0137763 | Ubiquitin mediated proteolysis |
| | 24 (2.33%) | 163 (1.07%) | 0.0002372665 | ABC transporters |
| | 20 (1.94%) | 138 (0.9%) | 0.0009303992 | Glucagon signaling pathway |
| | 22 (2.14%) | 169 (1.11%) | 0.002216142 | Insulin resistance |
| | 24 (2.33%) | 197 (1.29%) | 0.00347834 | Adherens junction |
| | 4 (0.39%) | 11 (0.07%) | 0.004603775 | Circadian rhythm – fly |
| | 7 (0.68%) | 35 (0.23%) | 0.007846637 | Circadian rhythm |
| | 14 (1.36%) | 105 (0.69%) | 0.01068485 | Inositol phosphate metabolism |
| | 13 (1.26%) | 95 (0.62%) | 0.01105092 | Antifolate resistance |
| | 10 (0.97%) | 65 (0.43%) | 0.01116436 | Glycosaminoglycan biosynthesis-heparan sulfate / heparin |
| | 10 (0.97%) | 65 (0.43%) | 0.01116436 | Vasopressin-regulated water reabsorption |
The top 10 immune-related KEGG pathways with the highest enrichment of DEGs in groups with different immune challenges
| Pathway ID | DEGs annotation in the pathway | All genes annotation in the pathway | Pathway annotation | |
|---|---|---|---|---|
| | 21 (1.71%) | 218 (1.43%) | 0.2218435 | Th1 and Th2 cell differentiation |
| | 20 (1.63%) | 208 (1.36%) | 0.2311792 | Leukocyte transendothelial migration |
| | 11 (0.9%) | 115 (0.75%) | 0.3179508 | Natural killer cell mediated cytotoxicity |
| | 14 (1.14%) | 155 (1.01%) | 0.3636409 | Fc gamma R-mediated phagocytosis |
| | 8 (0.65%) | 88 (0.58%) | 0.4117395 | Th17 cell differentiation |
| | 4 (0.33%) | 42 (0.27%) | 0.4392712 | Primary immunodeficiency |
| | 9 (0.73%) | 105 (0.69%) | 0.4703544 | Cytosolic DNA-sensing pathway |
| | 4 (0.33%) | 46 (0.3%) | 0.5109961 | Hematopoietic cell lineage |
| | 8 (0.65%) | 98 (0.64%) | 0.5344647 | Fc epsilon RI signaling pathway |
| | 2 (0.16%) | 23 (0.15%) | 0.561599 | Intestinal immune network for IgA production |
| | 6 (0.4%) | 23 (0.15%) | 0.02188151 | Intestinal immune network for IgA production |
| | 28 (1.84%) | 208 (1.36%) | 0.05993948 | Leukocyte transendothelial migration |
| | 17 (1.12%) | 115 (0.75%) | 0.06204072 | Natural killer cell mediated cytotoxicity |
| | 21 (1.38%) | 155 (1.01%) | 0.08842557 | Fc gamma R-mediated phagocytosis |
| | 13 (0.86%) | 98 (0.64%) | 0.1727241 | Fc epsilon RI signaling pathway |
| | 13 (0.86%) | 105 (0.69%) | 0.2419115 | Cytosolic DNA-sensing pathway |
| | 6 (0.4%) | 46 (0.3%) | 0.3049254 | Hematopoietic cell lineage |
| | 12 (0.79%) | 102 (0.67%) | 0.312857 | B cell receptor signaling pathway |
| | 13 (0.86%) | 118 (0.77%) | 0.3906605 | Toll-like receptor signaling pathway |
| | 5 (0.33%) | 42 (0.27%) | 0.4066475 | Primary immunodeficiency |
| | 17 (1.65%) | 155 (1.01%) | 0.03195124 | Fc gamma R-mediated phagocytosis |
| | 18 (1.75%) | 188 (1.23%) | 0.08324536 | Chemokine signaling pathway |
| | 5 (0.49%) | 42 (0.27%) | 0.1499922 | Primary immunodeficiency |
| | 11 (1.07%) | 115 (0.75%) | 0.1515229 | Natural killer cell mediated cytotoxicity |
| | 3 (0.29%) | 23 (0.15%) | 0.1992882 | Intestinal immune network for IgA production |
| | 9 (0.87%) | 98 (0.64%) | 0.2139022 | Fc epsilon RI signaling pathway |
| | 8 (0.78%) | 88 (0.58%) | 0.2403939 | Th17 cell differentiation |
| | 2 (0.19%) | 14 (0.09%) | 0.2423557 | Inflammatory bowel disease (IBD) |
| | 9 (0.87%) | 102 (0.67%) | 0.2484696 | B cell receptor signaling pathway |
| | 9 (0.87%) | 105 (0.69%) | 0.2755423 | Cytosolic DNA-sensing pathway |
Fig. 4Changes in expression of cytokine genes upon immune challenges of LPS, Poly (I: C) and V. harveyi. a The periphery of the circle is the X-axis which presents cytokine genes, while the radius of the circle is the Y-axis which presents the log 2 fold changes value of LPS, Poly (I:C) and V. harveyi immune challenges of corresponding cytokine genes. The closer from the edge of the circle the higher the up regulated expression of corresponding gene is, and the closer from the center of the circle the higher the down regulated expression of corresponding gene is. b two-dimensional hierarchical clustering performed on the clusters of cytokine genes FPKM under three different stimulis. The pink and blue color represents the up- and down-regulation, respectively
Fig. 5Bioinformatics analysis of selected cytokines. a Phylogenetic analysis of the selected cytokines family with maximum-likelihood (ML) method. b The structural domains of some of the cytokines
Fig. 6Dose-increased expression of cytokine genes. Transcriptional expression of H. leucospilota cytokines gene, with the β-actin as reference gene, in the sea cucumber coelomocytes treated respectively with LPS concentration of 10.0 μg/ml, 20.0 μg/ml, 50.0 μg/ml for 24 h. The data presented are expressed as the mean ± S.E. (n = 3). The same letter in the experimental groups represent a similar level (p > 0.05, ANOVA followed by Fisher’s LSD test)
Primers designed for RT-qPCR of DEGs
| Gene ID | Forward primer sequences (5′-3′) | Reverse primer sequences (5′-3′) | |
|---|---|---|---|
| | 0 | TCACGGCATTGAGAACGG | CGGTGTCTGAACTTTGGGT |
| | 0 | CAGACAAAAGCCTCAGAAATG | AAGAACCCAGAGCTGGAAAG |
| | 0 | ATACGAAAAGCGGCAAACA | TCCATCTCAGACCCCAACTC |
| | 0 | TCCATCTCAGACCCCAACTC | TTTCCATTGGGAGGTAAGC |
| | 0 | TCACTGCGGCATTGATTC | GGTGCCCTTCCGTCAATT |
| | 0 | GTGCAAAGAAGGGAAGGC | TCTGGTGATTTATGTTGTGGG |
| | 0 | ACTCATGTGGATGGCACTAGC | GGAAGAAGGGACAGAATAAACC |
| | 1.89E-260 | AAGGATTATGGACGGGACAC | TTCTCAAACCACCAGAGGG |
| | 0 | GTCAAACCAATAACAGCGAAAG | TGGACCAGACCAGGCAAA |
| | 0 | CGTGCTTGCCGAGTTTGT | GCAGGCTATTGCTGTTGTTAA |
| | 0 | AAGCAAGATAGACACTGTGGTTC | GATTGATGCCCCGTAAGC |
| | 0 | AGGGTAACAGGTTGGGTGAA | GCAGTAGTTGGAGCCATTGAA |
| | 0 | TGCGTTTGTTGACTTTTGC | TGAAATGGTTCCGATTCTCA |
| | 0 | TTTGCTGGAGTATTGTGGTTC | TGGGCTGTAGGGGCTTTA |
| | 2.03E-139 | ACCCCAGATGACCTTTGACC | GTTAACACAATTTCTCCAGTTAGGA |
| | 1.05E-297 | AGTTGATATTCACCAGCCTTGC | CCACTTTCCATGAAACCGTAA |
| | 2.56E-93 | GGAGGTCAATGGTCATTTGG | ACCCCTGGTGACCCTACAT |
| | 7.31E-233 | AAACACGGTATCTCCAGAATGA | AATGACCTTTGACCTCCACC |
| | 0 | TTCAAAAGCAGTGCCAACG | CATTATCATCATCTTGCCGAAC |
| | 2.50E-62 | CCACTTGGACAGCAGTGAAG | TGATGACCTGGTTTGAGAAGAC |
| | 0.000883536 | CGCAAAGGATTGTGATGGT | ACAGGAAGAGGCTATACAGACG |
| | 0.013152297 | CTTACTGGGTTGGTAGTTTTGAC | GTGCGTTCTTGCCATTCTC |
| | 0.00023473 | TCTTGCTTCTCACCCGATTT | CCGTAGGGGACACCTCTTT |
| | 5.57E-09 | TGGTGGAATAGTGGAGGGTG | GACTGGTTGGTTGAGGCTGT |
| | 0.003436624 | AACAGACGGACAGTCATACAGC | TGGTTGAGCCCTTGATAGTG |
| | 0.005767319 | CATTCCAGTTGGTGATGGC | TGATTTCCTCACCGCATTT |
| | 2.23E-07 | CAGAAAGCCTGGGTAAAGC | GACCTGGACCAAACCTCATT |
| | 0.101229003 | TTACAAGACTATCCTCCCCTCA | GCGATGCGATACTGATAAAGG |
| | 0.311031428 | ATGGCTTTTGAGGATGGTG | GCTGCTGTATCTCAGGAGGAAA |
| | 0.000470648 | ACCAACCACCATCCAACTG | TTCTCCTGATCCACCCCTAA |
| | 0.001415506 | TCCCTTTATTGTTCCTGTGG | TGTCTCCGCTTTCCTGTAGTA |
| | 1.94E-07 | AGGCTGGCTCGCTTCTT | ACGCTATCGCTCATTGGAC |
| | 5.40E-08 | GTTGAGGCATTCACATTTCG | AACTTTCGGCAGTCCTTACAG |
| | 1.36E-05 | TACCATAGGAAGGGGATCTGT | AGACTTGCCCGACGATTT |
| | 3.56E-23 | AGGCACTCTTCTGCATTCTCC | GCTACTGAACGCTTGTTGACG |
| | 1.90E-07 | CGGCGGCATACAACAGA | ACATTGGGCATCCAGAACA |
| | 0.003209029 | GGTCCAAAGAAAGGCATCA | GGCTTGAAAGTAAGAAACCGT |
| | 5.20E-08 | GATTCAGCCTTCATTTTGGA | GCTTAGTATCTTTGGGTCTGTCTA |
| | 0.000343861 | GATTCAGCCTTCATTTTGGA | GCTTAGTATCTTTGGGTCTGTCTA |
| | 0.7252968 | TGGTCCAAGTGGTCTCCCT | CTGGTCCTCTGGTAAACAGTCAT |
| | 0.086692271 | CAGGAGTCTTATTTGGTATCTATGC | CAATGTGGCGATGGTGTTC |